Open Science, June 2024

      Innovation drives progress: The evolution of smoke-free products

      Discover how innovation can drive the development of products with significantly lower risk profiles than cigarettes, and the scientific evidence developed to date on the potential positive impact of these scientifically substantiated products on population harm reduction. In this Open Science event, we took a deep dive into this discussion with our panelists, focusing on the example of our Tobacco Heating System (THS). 

      The harm reduction equation and product development

      The concept of the harm reduction equation is one of the guiding principles of our development of our smoke-free product portfolio. The primary goal of tobacco harm reduction is to achieve a positive impact on public health. Toward this end, we work to develop products whose risk profiles are significantly lower than that of cigarettes for adults who would otherwise continue to smoke.

       

      Evolving smoke-free products and their risk profile

      Once we have developed a new smoke-free product, we don’t stop there. We continue to improve the product, we continue to innovate. But even with the pace of innovation, the risk profile of our smoke-free products remains a high priority. In this Open Science event, our panelists presented our THS as an example. They explained the differences between IQOS, a heated tobacco product which relies on ceramic blade heating technology, and the next generation of tobacco heating called Iluma, which employs an inductive heating element. Then they showed how the evidence we’ve gathered on both products is comparable across the range of different studies we conduct, including among our clinical studies.

      Altogether, the totality of evidence, based on our research as well as independent studies, on our THS shows that its risk profile remains significantly lower than that of cigarettes regardless of which version is studied.

      Event Details

      See how product innovation relates to our products’ reduced-risk profiles

      This Open Science event took place live in Warsaw, Poland, and was hosted on LinkedIn®, YouTube, and the Open Science platform. Our experts showed that the totality of evidence on our THS shows that its risk profile remains significantly lower than that of cigarettes regardless of which version is studied.

      Replay

      This video contains minor modifications compared to the live broadcast.